Literature DB >> 34132839

Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration.

Matthias Barral1, Lionel Arrive2, Sanaa El Mouhadi-Barnier2, François H Cornelis3.   

Abstract

Entities:  

Year:  2021        PMID： 34132839     DOI： 10.1007/s00134-021-06458-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  3 in total

1.  Transjugular intrahepatic portosystemic shunt, local thrombaspiration, and lysis for management of fulminant portomesenteric thrombosis and atraumatic splenic rupture due to vector-vaccine-induced thrombotic thrombocytopenia: a case report.

Authors:  Sandra Emily Stoll; Patrick Werner; Wolfgang A Wetsch; Fabian Dusse; Alexander C Bunck; Matthias Kochanek; Felix Popp; Thomas Schmidt; Christiane Bruns; Bernd W Böttiger
Journal:  J Med Case Rep       Date:  2022-07-11

2.  Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review.

Authors:  Usama Waqar; Shaheer Ahmed; Syed M H Ali Gardezi; Muhammad Sarmad Tahir; Zain Ul Abidin; Ali Hussain; Natasha Ali; Syed Faisal Mahmood
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

3.  Gender and AB0 Blood Type Differences in a Unicentric Group of University Professors in Southern Italy Who Received the Vaxzevria COVID-19 Vaccine: A Cross-Sectional Survey of Vaccine Side Effects, Attitudes, and Hesitation.

Authors:  Silvana Mirella Aliberti; Luigi Schiavo; Giovanni Boccia; Emanuela Santoro; Gianluigi Franci; Alessandro Ruggiero; Francesco De Caro; Mario Capunzo
Journal:  Vaccines (Basel)       Date:  2022-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.